[]RS79948-197 binding to human, rat, guinea pig and pig α2A-, α2B- and α2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine
Introduction
Studies of the recombinant α2-adrenoceptor subtypes have shown that they correlate pharmacologically well with the corresponding subtypes of native tissues (Uhlén et al., 1992; Bylund et al., 1992). In a report from the `IUPHAR Nomenclature of Adrenoceptors Committee' these α2-adrenoceptor subtypes were designated α2A-, α2B- and α2C (Bylund et al., 1994). The rat and the human orthologs of the α2A-adrenoceptor show discrepant pharmacology and the rat ortholog has been designated as the α2D-adrenoceptor, but there is now the general consensus that there are only three α2-adrenoceptor subtypes within one single species (Hieble and Bond, 1994).
In the present study, the Kd values of the recently introduced radioligand []RS79948-197 ((8aR,12aS,13aS)-5,8,8a,9,10,11,12,12a,13,13a-decahydro-3-methoxy-12-(ethylsulphonyl)-6H-isoquino[2,1-g][1,6]naphthyridine; Hume et al., 1996; Milligan et al., 1997) were determined for the expressed human and rat recombinant α2A-, α2B- and α2C-, for guinea pig recombinant α2B- and α2C-adrenoceptors and for guinea pig native α2A-adrenoceptors in spleen membranes. In addition, we determined the affinity of []RS79948-197 for the pig α2A-, α2B- and α2C-adrenoceptors in striatal and kidney membranes.
Available α2-adrenoceptor radioligands, besides []RS79948-197, are []MK912 ((2S,12bS)1′,3′-dimethylspiro(1,3,4,5′,6,6′,7,12b-octahydro-2H-benzo[b]furo[2,3-a]quinazoline)-2,4′-pyrimidin-2′-one), []RX821002 (2-methoxy-idazoxan), []rauwolscine and []yohimbine. When radioligand binding is applied in tissues containing more than one α2-adrenoceptor subtype, the less abundant population could often be detected only by the use of a subtype-selective radioligand. For example, the use of the α2C-selective radioligand []MK912 (Pettibone et al., 1989) enabled the detection of both α2A- and α2C-adrenoceptors in the rat spinal cord (Uhlén et al., 1992), even though the α2C-adrenoceptors constituted only 5% of the total α2-adrenoceptor population in this particular tissue.
In some recent studies from our laboratory, we determined the Kd values of MK912, RX821002, rauwolscine and yohimbine for α2A-, α2B- and α2C-adrenoceptors in different species. From the present and our previous studies, where exactly the same assay conditions were used, we are now able to compile a complete table of the Kd values and thereby the subtype selectivities, of []RS79948-197, MK912, RX821002, rauwolscine and yohimbine for all of the human, rat, guinea pig and pig α2-adrenoceptor subtypes. The data should enable researchers to choose the most appropriate α2-adrenoceptor radioligands for their particular studies.
Section snippets
Isotopes and drugs
The following isotopes and drugs were used: []MK912 (83 Ci/mmol) was purchased from New England Nuclear (NEN) through DuMedical AB, Stockholm, Sweden. [Ethyl-]RS79948-197 (76 Ci/mmol) was purchased from Amersham through Amersham Sweden AB, Solna, Sweden. For the structure of RS79948-197 see Hume et al. (1996). BDF8933 (4-fluoro-2-(imidazoline-2-ylamino)-isoindoline; Armah, 1988) was a gift from Beiersdorf AG, Hamburg, Germany; BRL44408
Determination of the Kd values of []RS79948-197 for the recombinant human α2A-, α2B- and α2C-adrenoceptors
In order to determine the Kd values of []RS79948-197 for the human α2A-, α2B- and α2C-adrenoceptors saturation experiments were performed. In these experiments one plain curve, representing total binding and one curve where binding was blocked by 2 μM BDF8933 (representing non-specific binding), were obtained. As can be seen in Table 1 the Kd values of []RS79948-197 for the human α2-adrenoceptors ranged between 0.46 and 0.77 nM.
Determination of the Kd values of []RS79948-197 for the recombinant rat α2A-, α2B- and α2C-adrenoceptors
The Kd values of []RS79948-197 for the rat α2A-, α2B- and α2C
Discussion
In the present paper the binding properties of the recently introduced α2-adrenoceptor antagonist radioligand []RS79948-197 were investigated. It was found that []RS79948-197 had high affinity for each of the human, rat, pig and guinea pig α2A-, α2B- and α2C-adrenoceptors. Combined with its low non-specific binding, this makes []RS79948-197 a good general radioligand for α2-adrenoceptors.
For the human and rat α2A-, α2B- and α2C-adrenoceptors, and for the guinea pig α2B- and α2C
Acknowledgements
Supported by the Swedish MRC (04X-05957) and the Berth von Kantzow, the Magnus Bergwall, the Clas Groschinsky and the Åke Wiberg foundations.
References (36)
- et al.
High affinity binding of -rauwolscine and -RX781094 to α2-adrenergic receptors and non-stereoselective sites in human and rabbit brain membranes
Biochem. Pharmacol.
(1989) - et al.
α2-Adrenoceptors take centre stage at Nashville meeting
Trends Pharmacol. Sci.
(1996) - et al.
Evaluation in rat of RS-79948-197 as a potential PET ligand for central α2-adrenoceptors
Eur. J. Pharmacol.
(1996) - et al.
Two human α2-adrenoceptor subtypes α2A-C10 and α2B-C2 expressed in insect cells couple to transduction pathway resulting in opposite effects on cAMP production
Eur. J. Pharmacol.
(1995) - et al.
Isolation of rat genomic clones encoding subtypes of the α2-adrenergic receptor
J. Biol. Chem.
(1991) - et al.
Protein measurement with the folin phenol reagent
J. Biol. Chem.
(1951) - et al.
Functional analysis of the human α2C-C4 adrenergic receptor in insect cells expressed by luciferase-based baculovirus vector
Biochim. Biophys. Acta
(1993) - et al.
[]-L-657,743 (-MK912): A new, high affinity, selective radioligand for brain α2-adrenoceptors
Life Sci.
(1989) - et al.
Heterologous expression of the cloned guinea pig α2A, α2B, and α2C adrenoceptor subtypes
Biochem. Pharmacol.
(1996) - et al.
Delineation of rat kidney α2A and α2B adrenoceptors with -RX821002 radioligand binding: Computer modelling reveals that guanfacine is an α2A-selective compound
Eur. J. Pharmacol.
(1991)
Identification of drugs subtype-selective for α2A-, α2B-, and α2C-adrenoceptors in the pig cerebellum and kidney cortex
Eur. J. Pharmacol.
BDF8933: A novel alpha-2-receptor antagonist lacking the potential to induce noradrenaline overflow
Naunyn-Schmiedebergs Arch. Pharmacol.
The contribution of α2-noradrenergic mechanisms to prefrontal cortical cognitive function
Arch. Gen. Psychiatry
Alpha-2 adrenoceptor assayed in rat brain by the new ligand []RX821002
Biog. Amines
Heterogeneity of alpha2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide
Br. J. Pharmacol.
Pharmacological characteristics of α2-adrenergic receptors: Comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning
Mol. Pharm.
International Union of Pharmacology Nomenclature of Adrenoceptors
Pharmacol. Rev.
Buffers differentially alters the binding of []rauwolscine and []RX821002 to the alpha-2 adrenergic receptor subtypes
J. Pharmacol. Exp. Ther.
Cited by (80)
Preclinical evaluation of new C-11 labeled benzo-1,4-dioxane PET radiotracers for brain α2C adrenergic receptors
2022, European Journal of Medicinal ChemistryNovel technique to determine the pK<inf>A</inf> of clonidine at prejunctional α<inf>2</inf>-adrenoceptors in cardiac and vascular sympathetic transmission
2017, European Journal of PharmacologyCitation Excerpt :Evidence that prejunctional α2-adrenoceptors are activated by transmitter noradrenaline is given by the response to yohimbine and benextramine. Yohimbine is a potent α2-adrenoceptor antagonist with Kd values of 3.7 nM (pKD 8.43) in human α2A receptor binding assays and 50 nM (pKD 7.3) and 41 nM (pKD 7.4) in rat and guinea pig (Uhlén et al., 1998). Yohimbine (0.1 µM) caused similar increases to atrial responses as benextramine (3 µM) pretreatment but only when higher field pulses (>8) were used.
A new, simple and robust radioligand binding method used to determine kinetic off-rate constants for unlabeled ligands. Application at α<inf>2A</inf>- and α<inf>2C</inf>-adrenoceptors
2016, European Journal of PharmacologyCitation Excerpt :3H]-RX821002 is therefore an excellent radioligand for the study. Spiroxatrine and chlorpromazine were chosen to be tested because these molecules are bulky and α2C/α2B- over α2A-selective (Laurila et al., 2011), MK912 because it is bulky and α2C- but not α2B- over α2A-selective (Uhlén et al., 1998), BRL44408 because it is α2A-selective, and atipamezole and RX820102 because they are small and non-selective molecules (Jahnsen and Uhlén, 2013), RS79948–197 and yohimbine were included since they are non-selective (Uhlén et al., 1998), but structurally remind of MK912. The drug MK912 sticks to polystyrene (PS) surfaces, but not to polypropylene (PP) (Uhlén et al., 1994).
Acute vagal nerve stimulation lowers α2 adrenoceptor availability: Possible mechanism of therapeutic action
2015, Brain StimulationCitation Excerpt :We recently developed [11C]yohimbine, an antagonist primarily of the α2 adrenoreceptors, as a tracer of noradrenergic neurotransmission by means of PET, and validated its use in pigs [11]. In pharmacological doses, yohimbine is not exclusively selective for α2 receptors, as it has been reported to bind with moderate or weak affinity to other receptors in vitro, such as D2, α1 and 5HT1A, albeit with 5–10-fold lower affinity [12–14]. However, in tracer concentrations, yohimbine is highly selective for α2 sites in vivo [11].
Peripheral α<inf>2</inf>-β<inf>1</inf> adrenergic interactions mediate the ghrelin response to brain urocortin 1 in rats
2014, PsychoneuroendocrinologyRole of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats
2014, Behavioural Brain ResearchCitation Excerpt :We found that this reinstatement is attenuated by the α-2 adrenoceptor agonist clonidine and the 5-HT1A antagonist WAY 100,635 [78]. It is unlikely, however that selective antagonism of α-2 adrenoceptor is critical for YOH's effect on reinstatement, because the selective α-2 adrenoceptor antagonist RS79948 [79] does not reinstate alcohol or food seeking [78,80]. Finally, data from two recent studies on YOH-induced reinstatement of food seeking [81,82] suggest that activation of prefrontal dopamine by YOH [83] is downstream of YOH-induced prefrontal noradrenaline release (Millan et al., [73]).